Zu diesem Instrument liegen derzeit keine aktuellen Daten vor.
Anlagepolitik
So investiert der LO Selection - NextGen BioTech Syst. Hdg CHF PD Fonds: The Sub-Fund invests primarily in equity securities or equity-related securities issued by companies worldwide (including Emerging Markets) exercising a prominent part of their business activities in the healthcare industry. The Investment Manager’s approach focuses on small and mid-cap biotechnology companies providing positive impact through disruptive, next generation innovations that can bring, among other things, better treatment solutions while lowering the financial burden for society.
Rating für LO Selection - NextGen BioTech Syst. Hdg CHF PD Fonds
| €uro FondsNote | - |
Fonds Performance: LO Selection - NextGen BioTech Syst. Hdg CHF PD Fonds
| Performance 1 Jahr | 11,40 | |
| Performance 2 Jahre | -33,78 | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
Fundamentaldaten
| WKN | A2QKBJ |
| ISIN | LU2265259551 |
| Name | LO Selection - NextGen BioTech Syst. Hdg CHF PD Fonds |
| Fondsgesellschaft | Lombard Odier Funds |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 14.01.2021 |
| Kategorie | Branchen: Andere Sektoren |
| Währung | CHF |
| Volumen | 261 245 139,25 |
| Depotbank | CACEIS Bank, Luxembourg Branch |
| Zahlstelle | Bank Lombard Odier & Co AG |
| Fondsmanager | Jérôme Berton |
| Geschäftsjahresende | 30.09. |
| Berichtsstand | 31.05.2023 |
Konditionen
| Ausgabeaufschlag | % |
| Verwaltungsgebühr | % |
| Depotbankgebühr | % |
| VL-fähig? | Nein |
| Mindestanlage | 3 053,09 |
| Ausschüttung | Ausschüttend |
Fondsgesellschaft
| Name | Lombard Odier Funds (Europe) SA |
| Postfach | 291, route d’Arlon |
| PLZ | L-1150 |
| Ort | Luxembourg |
| Land | |
| Telefon | 00352 27 78 5000 |
| Fax | |
| Internet | http://www.loim.com |